Federal contract award
75F40122C00182
ADVANCING IN VITRO AND (PATHO)PHYSIOLOGY-BASED PHARMACOKINETICS MODELS TO UNDERSTAND AND PREDICT PULMONARY ABSORPTION AND TISSUE RETENTION OF INHALED DRUGS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $1.8M |
| Start date | Sep 21, 2022 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Jan 17, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 17, 2025 | P00002 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 29, 2026. |
| Nov 8, 2022 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE VENDOR UEI FROM LFZGKJMDW747 TO NNFQH1JAPEP3. |
| Sep 21, 2022 | 0 | $1.8M | ADVANCING IN VITRO AND (PATHO)PHYSIOLOGY-BASED PHARMACOKINETICS MODELS TO UNDERSTAND AND PREDICT PULMONARY ABSORPTION AND TISSUE RETENTION OF INHALED DRUGS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.